Literature DB >> 9682357

Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana.

C R González1, F R Noriega, S Huerta, A Santiago, M Vega, J Paniagua, V Ortiz-Navarrete, A Isibasi, M M Levine.   

Abstract

Attenuated Salmonella typhi are attractive for use as live vector vaccines to express protozoal antigens and deliver them to the human immune system. The gene encoding the mature form of Leishmania mexicana mexicana gp63 under control of tac promoter was integrated into the delta aroC locus of the chromosome of attenuated delta aroC, delta aroD S. typhi strain CVD 908. After oral immunization of BALB/c mice with two 1 x 10(9) colony forming unit doses given 21 days apart, CVD 908 omega (delta aroC::Ptac-gp63) elicited a broad T cell-mediated immune response against L. m. mexicana gp63 as demonstrated by: (1) lymphoproliferative response to fixed whole L. m. mexicana promastigotes; (2) activation of IL-2 (but not IL-4)-producing lymphocytes; (3) appearance of cytotoxic T cells against mouse mastocytoma cells expressing gp63. This T-cell mediated immune response was associated with significant protection in F1 (BALB/cXC57Bl/6) mice challenged in their footpads with a wild type strain of L. m. mexicana.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682357     DOI: 10.1016/s0264-410x(97)00267-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Two Salmonella OmpC K(b)-restricted epitopes for CD8+-T-cell recognition.

Authors:  Alberto Diaz-Quiñonez; Natalia Martin-Orozco; Armando Isibasi; Vianney Ortiz-Navarrete
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis.

Authors:  Beatriz Coutinho De Oliveira; Malcolm S Duthie; Valéria Rêgo Alves Pereira
Journal:  Hum Vaccin Immunother       Date:  2019-11-11       Impact factor: 3.452

3.  Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.

Authors:  D Bumann
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production.

Authors:  Feng Qian; Weiqing Pan
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 5.  Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis.

Authors:  Malcolm S Duthie; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

6.  Type IVB pilus operon promoter controlling expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid gene in Salmonella enterica Serovar Typhi elicits full immune response by intranasal vaccination.

Authors:  Fengling Luo; Yong Feng; Min Liu; Pingfei Li; Qin Pan; Victor Tunje Jeza; Bing Xia; Jianguo Wu; Xiao-Lian Zhang
Journal:  Clin Vaccine Immunol       Date:  2007-06-27

7.  Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes.

Authors:  Marcela F Pasetti; Rosangela Salerno-Gonçalves; Marcelo B Sztein
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

8.  Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates.

Authors:  Olukemi O Ifeonu; Raphael Simon; Sharon M Tennant; Abhineet S Sheoran; Maria C Daly; Victor Felix; Jessica C Kissinger; Giovanni Widmer; Myron M Levine; Saul Tzipori; Joana C Silva
Journal:  Database (Oxford)       Date:  2016-10-19       Impact factor: 3.451

9.  Immunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies.

Authors:  Rory C F Brito; Frederico G Guimarães; João P L Velloso; Rodrigo Corrêa-Oliveira; Jeronimo C Ruiz; Alexandre B Reis; Daniela M Resende
Journal:  Int J Mol Sci       Date:  2017-02-10       Impact factor: 5.923

Review 10.  Live vaccination tactics: possible approaches for controlling visceral leishmaniasis.

Authors:  Noushin Saljoughian; Tahareh Taheri; Sima Rafati
Journal:  Front Immunol       Date:  2014-03-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.